Scalzo Richard William Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
32
Insider Sells Sum
$8.71M

Insider Activity of Scalzo Richard William

According to the SEC Form 4 filings, Scalzo Richard William, being in a position of

  1. Chief Financial Officer at Crescent Biopharma, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 1680 shares for $30,172,
    over all time since 2026-06-22, has bought 0 shares, and sold 1680 shares for $30,172.

Biography of Scalzo Richard William

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $30,1722100

Comparison of Insiders on Amount of Buys and Sells

2026-09-16SaleCrescent Biopharma, Inc.
CBIO
Chief Financial Officer
568
0.0016%
$17.90$10,167-19.94%
2026-06-22SaleCrescent Biopharma, Inc.
CBIO
Chief Financial Officer
1,112
0.0041%
$17.99$20,005-6.49%
2025-03-11SaleDyne Therapeutics, Inc.
DYN
SVP, Head of Finance & Admin.
1,343
0.0011%
$11.38$15,283+10.56%
2025-03-05SaleDyne Therapeutics, Inc.
DYN
SVP, Head of Finance & Admin.
917
0.0008%
$11.83$10,848+8.7%
2025-02-18SaleDyne Therapeutics, Inc.
DYN
SVP, Head of Finance & Admin.
2,488
0.0025%
$13.95$34,708-4.43%
2024-12-11SaleDyne Therapeutics, Inc.
DYN
SVP, Head of Finance & Admin.
1,455
0.0015%
$28.12$40,915-52.09%
2024-11-18SaleDyne Therapeutics, Inc.
DYN
SVP, Head of Finance & Admin.
2,735
0.0025%
$28.20$77,127-55.15%
2024-09-18SaleDyne Therapeutics, Inc.
DYN
SVP, Head of Finance & Admin.
1,390
0.0015%
$34.55$48,025-60.88%
2024-09-11SaleDyne Therapeutics, Inc.
DYN
SVP, Head of Finance & Admin.
1,468
0.0015%
$31.89$46,815-58.56%
2024-09-06SaleDyne Therapeutics, Inc.
DYN
SVP, Head of Finance & Admin.
126,074
0.1301%
$32.15$4.05M-58.86%
2024-08-19SaleDyne Therapeutics, Inc.
DYN
SVP, Head of Finance & Admin.
2,752
0.004%
$45.12$124,174-69.88%
2024-06-11SaleDyne Therapeutics, Inc.
DYN
SVP, Head of Finance & Admin.
1,331
0.0013%
$31.34$41,714-9.77%
2024-06-10SaleDyne Therapeutics, Inc.
DYN
SVP, Head of Finance & Admin.
1,590
0.0015%
$30.23$48,066-10.63%
2024-05-16SaleDyne Therapeutics, Inc.
DYN
SVP, Head of Finance & Admin.
2,588
0.0023%
$28.27$73,162+2.23%
2024-03-11SaleDyne Therapeutics, Inc.
DYN
SVP, Head of Finance & Admin.
2,672
0.0022%
$25.28$67,542+15.11%
2024-03-08SaleDyne Therapeutics, Inc.
DYN
SVP, Head of Finance & Admin.
86,252
0.0726%
$26.22$2.26M+17.01%
2024-03-07SaleDyne Therapeutics, Inc.
DYN
SVP, Head of Finance & Admin.
2,273
0.0019%
$25.85$58,757+11.23%
2024-03-01SaleDyne Therapeutics, Inc.
DYN
SVP, Head of Finance & Admin.
9,311
0.0084%
$28.25$262,999+1.06%
2024-02-29SaleDyne Therapeutics, Inc.
DYN
SVP, Head of Finance & Admin.
3,429
0.003%
$27.50$94,298+9.33%
2024-01-26SaleDyne Therapeutics, Inc.
DYN
SVP, Head of Finance & Admin.
13,000
0.0102%
$24.34$316,420+39.13%
Total: 34
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.